Insider Transactions in Q2 2024 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q2 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 24
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
11,084
-21.78%
|
$11,749,040
$1060.13 P/Share
|
Jun 24
2024
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
14,450
+22.12%
|
$8,019,750
$555.67 P/Share
|
Jun 24
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
756
-35.36%
|
$802,872
$1062.0 P/Share
|
Jun 24
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
756
+26.12%
|
$280,476
$371.4 P/Share
|
Jun 14
2024
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,535
-52.62%
|
$1,596,400
$1040.0 P/Share
|
Jun 14
2024
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,535
+34.48%
|
$959,375
$625.6 P/Share
|
Jun 12
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
16,149
-42.55%
|
$16,455,831
$1019.06 P/Share
|
Jun 12
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
BUY
Conversion of derivative security
|
Indirect |
1,000
+50.0%
|
-
|
Jun 11
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
9,064
-7.23%
|
$9,199,960
$1015.66 P/Share
|
Jun 10
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Bona fide gift
|
Indirect |
1,608
-100.0%
|
-
|
Jun 10
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Bona fide gift
|
Indirect |
37,900
+40.34%
|
-
|
Jun 10
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Bona fide gift
|
Indirect |
75,799
-100.0%
|
-
|
Jun 06
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Indirect |
787
-1.21%
|
$798,805
$1015.02 P/Share
|
Jun 05
2024
|
Bonnie L Bassler Director |
SELL
Open market or private sale
|
Direct |
827
-37.44%
|
$836,097
$1011.0 P/Share
|
Jun 05
2024
|
Bonnie L Bassler Director |
BUY
Exercise of conversion of derivative security
|
Direct |
827
+27.24%
|
$314,260
$380.95 P/Share
|
Jun 03
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.03%
|
$99,100
$991.02 P/Share
|
Jun 03
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,138
-8.09%
|
$1,115,240
$980.16 P/Share
|
Jun 03
2024
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,138
+7.48%
|
$423,336
$372.46 P/Share
|
May 28
2024
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
1,172
-45.89%
|
$1,141,528
$974.86 P/Share
|
May 28
2024
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,172
+31.45%
|
$732,500
$625.6 P/Share
|
May 21
2024
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
1,865
-5.1%
|
$1,853,810
$994.9 P/Share
|
May 17
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Direct |
22,830
-2.33%
|
$22,350,570
$979.64 P/Share
|
May 16
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Direct |
50,000
-0.51%
|
$48,600,000
$972.93 P/Share
|
May 15
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Direct |
50,000
-0.23%
|
$48,850,000
$977.45 P/Share
|
May 15
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Direct |
10,941
-0.27%
|
$10,765,944
$984.03 P/Share
|
May 14
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Open market or private sale
|
Direct |
25,000
-2.9%
|
$24,475,000
$979.63 P/Share
|
May 13
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
144,433
-25.0%
|
$140,966,608
$976.79 P/Share
|
May 13
2024
|
Leonard S Schleifer Bd. Co-Chair, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
203,204
+26.02%
|
$81,078,396
$399.66 P/Share
|
May 03
2024
|
George L Sing Director |
SELL
Payment of exercise price or tax liability
|
Direct |
877
-3.09%
|
$826,134
$942.53 P/Share
|
May 03
2024
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.59%
|
$826,000
$413.33 P/Share
|
May 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$90,100
$901.47 P/Share
|
May 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.9%
|
$222,250
$889.41 P/Share
|
Apr 29
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Bona fide gift
|
Indirect |
18,148
+50.0%
|
-
|
Apr 29
2024
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Bona fide gift
|
Indirect |
36,296
-100.0%
|
-
|
Apr 01
2024
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
250
-1.86%
|
$241,000
$964.73 P/Share
|
Apr 01
2024
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$96,100
$961.56 P/Share
|